British journal of cancer (2009 Sep)
Issue 6 p. 992-7 issn:1532-1827)
Colorectal cancer (CRC) is a leading cause of cancer-related morbidity and mortality in developed countries. It is known that early detection results in improved survival, and consequently there is a need for improved diagnostic tools in CRC. The plasma level of soluble urokinase plasminogen activator receptor (suPAR) was proposed as a marker in CRC patients. This study was undertaken to evaluate the individual molecular forms of suPAR as discriminators in a group of patients undergoing endoscopical examination following symptoms related to colorectal cancer.
Forfattere: Lomholt AF, Høyer-Hansen G, Nielsen HJ, Christensen IJ
